09.22.26 -- Building Smarter Fill-Finish Operations

Learn how expanding capacity, automation, and flexible manufacturing technologies are helping biologics manufacturers meet evolving market and quality demands.

When working with high-value biologics, ADCs, and personalized medicines, material utilization decisions made before GMP manufacturing can make or break your program yield. Learn how early choices matter.

Elevate sterile filtration with a dual-layer membrane design that boosts flow, minimizes fouling, and preserves product quality for consistent, efficient performance.

A look at sterile injectable expansion highlighting investment, advanced fill‑finish technologies, and flexible manufacturing from development to commercial production.

An inside look at a modern Annex 1–compliant sterile facility designed for flexible aseptic and terminally sterilised manufacturing across multiple drug delivery routes.

Recent studies offer insights on formulation, device compatibility, stability testing, and fill‑finish optimization — helping teams boost product performance and cut development risk.

Integrated fill‑finish capabilities across multiple sterile formats improve workflow efficiency, enhance product consistency, and support effective planning for long‑term commercialization.

USP <382> testing assesses packaging integrity, safety, and performance using deterministic CCIT and functional evaluations to support validation and regulatory submissions.

Patricia Krainski highlights PCI’s global sterile fill‑finish and lyophilization strengths, showcasing investments that expand capacity, technologies, and integrated solutions for complex biologics, formulations, and lyophilized products.

An optimized nest design for pre-fillable cartridges was designed using numerical simulation and data analytics to improve efficiency in pharmaceutical production.

We have an innovative business model that does not add additional costs to your project. Review our network's regulatory starting material capabilities below and contact us to simplify your outsourcing solutions.

With industry-leading viral expertise, Recipharm Advanced Bio navigates the rapidly evolving field of virotherapy to support the development and manufacturing of your gene therapies, viral vector vaccines and oncolytic viruses (OVs).